Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Helsinki
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ORNAV:FH

29.7100 EUR 0.2700 0.90%

As of 11:29:59 ET on 04/27/2015.

Snapshot for Orion Oyj (ORNAV)

Open: 29.0000 Day's Range: 29.0000 - 30.1900 Volume: 41,409
Previous Close: 29.9800 52wk Range: 21.5500 - 31.1100 1-Yr Rtn: +31.32%

Stock Chart for ORNAV

No chart data available.
  • ORNAV:FH 29.7100
  • 1D
  • 1M
  • 1Y
29.9800
Interactive ORNAV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORNAV

Current P/E Ratio (ttm) 19.8067
Estimated P/E(12/2015) 23.8826
Relative P/E vs. HEXP 0.8937
Earnings Per Share (EUR) (ttm) 1.5000
Est. EPS (EUR) (12/2015) 1.2440
Est. PEG Ratio -
Market Cap (M EUR) 4,229.04
Shares Outstanding (M) 40.41
30 Day Average Volume 22,453
Price/Book (mrq) 8.1178
Price/Sale (ttm) 4.1163
Dividend Indicated Gross Yield 4.38%
Cash Dividend (EUR) 1.3000
Dividend Ex-Date 03/25/2015
5 Year Dividend Growth 3.40%
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORNAV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ORNAV

Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.

Hannu SyrjaenenChairmanJukka YlppoVice Chairman
Timo LappalainenPresident/CEOJari KarlsonChief Financial Officer
More Company Profile & Key Executives for ORNAV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil